COMVERSE TECHNOLOGY INC/NY/
10-Q, 1995-11-08
TELEPHONE & TELEGRAPH APPARATUS
Previous: VICTORY PORTFOLIOS, DEFS14A, 1995-11-08
Next: MERCHANTS GROUP INC, 10-Q, 1995-11-08



<PAGE>
 
                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q


[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the quarterly period ended September 30, 1995

                                       or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
    EXCHANGE ACT OF 1934


                        COMMISSION FILE NUMBER:  0-15502


                           COMVERSE TECHNOLOGY, INC.
             (Exact name of registrant as specified in its charter)

          NEW YORK                                              13-3238402
(State or other jurisdiction of                            (I.R.S. Employer
 incorporation or organization)                            Identification No.)

170 CROSSWAYS PARK DRIVE, WOODBURY, NY                             11797
    (Address of principal executive offices)                     (Zip Code)

                                 (516) 677-7200
              (Registrant's telephone number, including area code)

                                 NOT APPLICABLE
              (Former name, former address and former fiscal year,
                         if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                                             [X] Yes               [ ] No


                     APPLICABLE ONLY TO CORPORATE ISSUERS:

        The number of shares of Common Stock, par value $0.10 per share,
               outstanding as of November 3, 1995 was 21,258,611


                            Page 1 of 18 Total Pages
                       (Exhibit Index Appears on Page 15)
<PAGE>
 
                                     PART I

                             FINANCIAL INFORMATION


                                                               Page
                                                               ----
 
ITEM 1.  Financial Statements

 1.      Condensed Consolidated Balance Sheets as
         of December 31, 1994 and September 30, 1995             3

 2.      Condensed Consolidated Statements of Income
         for the Three Month and Nine Month Periods
         Ended September 30, 1994 and September 30, 1995         4

 3.      Condensed Consolidated Statements of Stockholders'
         Equity for the Year Ended December 31, 1994 and the
         Nine Month Period Ended September 30, 1995              5

 4.      Condensed Consolidated Statements of Cash Flows
         for the Nine Month Periods Ended
         September 30, 1994 and September 30, 1995               6

 4.      Notes to Condensed Consolidated Financial
         Statements                                              7
 


 ITEM 2. Management's Discussion and Analysis of
         Financial Condition and Results of Operations           8





                                 Page 2 of 18
<PAGE>
 
                   COMVERSE TECHNOLOGY, INC. AND SUBSIDIARIES
                     CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (IN THOUSANDS)

<TABLE>
                            ASSETS                                                 LIABILITIES AND STOCKHOLDERS' EQUITY
<CAPTION>
 
                                   DECEMBER 31,   SEPTEMBER 30,                                      DECEMBER 31,   SEPTEMBER  30,
                                       1994            1995                                              1994            1995
                                                   (Unaudited)                                                        (Unaudited)
Current assets:                                                   Current liabilities:
<S>                                   <C>             <C>        <C>                                    <C>              <C>
 Cash and cash equivalents             $ 39,225        $ 80,336    Accounts payable and
 Bank time deposits and                                             accrued expenses                     $ 19,192         $ 27,208
   short-term investments                89,368          44,560    Advance payments
 Accounts receivable, net                24,181          35,187     from customers                          5,387            5,131
 Inventories                             12,427          16,015    Due to related parties                     278              338
 Prepaid expenses and                                              Other current liabilities                3,591              874
   other current assets                   4,591           6,538                                          --------         --------
                                       --------        -------- 
                                                                        Total current liabilities          28,448           33,551
    Total current  assets               169,792         182,636
                                                                   5-1/4% Convertible
                                                                     Subordinated Debentures               60,000           60,000
 
Long-term receivables, net                1,093           2,362   Liability for severance pay               1,352            2,331
                                                                  Other liabilities                           676            1,073
Property and equipment                   17,162          21,460   Minority interest                           413              320
Less:  accumulated depreci-                                                                              --------         --------
  ation and amortization                 (8,119)        (10,202)      Total liabilities                    90,889           97,275
                                       --------        --------
                                          9,043          11,258
                                                                  Stockholders' equity:
Investments                                 616           3,699   Common Stock, $.10 par value
                                                                  authorized 100,000,000 shares;
Goodwill, net                             1,384           1,354   issued and outstanding
                                                                  20,981,456 and 21,222,356                 2,098            2,122
Software development costs, net           6,512           8,374   Additional paid-in-capital               73,300           74,790
                                                                  Cumulative translation adjustment          (118)             (40)
Other intangible assets, net              1,827           1,663   Unrealized gain on available for
                                                                  sale securities, net of tax                  15              931
Deferred costs and other assets, net      2,235           1,922   Retained earnings                        26,318           38,190
                                       --------        --------                                          --------         --------
                                                                  Total stockholders' equity              101,613          115,993
                                                                                                         --------         --------
                                       $192,502        $213,268                                          $192,502         $213,268
                                       ========        ========                                          ========         ========
 
</TABLE>
    The accompanying notes are an integral part of these financial statements.

                                 Page 3 of 18
<PAGE>
 
                   COMVERSE TECHNOLOGY, INC. AND SUBSIDIARIES

                  CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                  (UNAUDITED)
                (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

<TABLE>
<CAPTION>
 
 
                                                  NINE MONTHS ENDED                       THREE MONTHS ENDED
                                                    SEPTEMBER 30,                           SEPTEMBER 30,
                                                   1994       1995                         1994       1995
<S>                                             <C>         <C>                          <C>        <C>
Revenues:                                                                         
     Sales                                       $ 78,818   $ 99,126                      $28,893    $36,116
     Interest and other income                      3,917      6,533                        1,452      2,209
                                                 --------   --------                      -------    -------
       Total revenues                              82,735    105,659                       30,345     38,325
- ------------------------------                   --------   --------                      -------    -------
                                                                                  
Costs and expenses:                                                               
     Research and development                      12,236     19,806                        4,448      7,078
     Less reimbursement                            (3,143)    (5,148)                      (1,049)    (1,846)
                                                 --------   --------                      -------    -------
     Net research and development                   9,093     14,658                        3,399      5,232
                                                                                  
     Cost of sales                                 34,909     42,879                       12,569     15,665
     Selling, general and administrative           24,041     29,594                        8,848     10,643
     Royalties and license fees                     1,880      1,828                          584        551
     Minority interest and equity                                                 
      in loss of affiliates                           280       (105)                         (15)       (60)
     Interest expense and other                     2,883      3,459                        1,145      1,017
                                                 --------   --------                      -------    -------
       Total costs and expenses                    73,086     92,313                       26,530     33,048
                                                 --------   --------                      -------    -------
                                                                                  
Income before income tax provision                  9,649     13,346                        3,815      5,277
Income tax provision                                1,289      1,474                          343        570
                                                 --------   --------                      -------    -------
                                                                                  
Net  income                                      $  8,360   $ 11,872                      $ 3,472    $ 4,707
                                                 ========   ========                      =======    =======
                                                                                  
Primary and fully diluted earnings per share        $0.38      $0.53                        $0.16      $0.21
                                                 ========   ========                      =======    =======
 
</TABLE>
 
   The accompanying notes are an integral part of these financial statements.

                                 Page 4 of 18
<PAGE>
 
                   COMVERSE TECHNOLOGY, INC. AND SUBSIDIARIES
            CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
              (UNAUDITED)        (IN THOUSANDS, EXCEPT SHARE DATA)
<TABLE>
<CAPTION>
 
                                                 Common Stock       Additional   Cumulative    Unrealized
                                                Number      Par      Paid in    Translation     Gains      Retained
                                              of Shares    Value     Capital     Adjustment    (Losses)    Earnings     Total
                                              ----------  -------  -----------  ------------  -----------  ---------  ---------
<S>                                           <C>         <C>      <C>          <C>           <C>          <C>        <C>
BALANCE AT JANUARY 1, 1994
    as previously reported                    19,814,461   $1,981     $73,047         $ (95)       $   -    $15,517   $ 90,450
Pooling of interests                           1,078,944      108         (98)            -            -      1,148      1,158
                                              ----------   ------     -------   -----------   ----------    -------   --------
Balance, as restated                          20,893,405    2,089      72,949           (95)           -     16,665     91,608
 
Adjustment to beginning balance for
    unrealized gain on available-for-sale
    securities, net of tax                             -        -           -             -          353          -        353
Unrealized loss on available-for-sale
    securities, net of tax                             -        -           -             -         (338)         -       (338)
Common stock issued in connection with
    exercise of stock options and warrants        88,051        9         351             -            -          -        360
Translation adjustment                                 -        -           -           (23)           -          -        (23)
Net income, year ended
    December 31, 1994                                  -        -           -             -            -     12,098     12,098
Adjustment to conform fiscal year
    of pooled company                                  -        -           -             -            -     (2,445)    (2,445)
                                              ----------   ------     -------   -----------   ----------    -------   --------
 
BALANCE AT DECEMBER 31, 1994                  20,981,456    2,098      73,300          (118)          15     26,318    101,613
 
Unrealized gain on available-for-sale
    securities, net of tax                             -        -           -             -          916          -        916
Common stock issued in connection with
    exercise of stock options and warrants       230,204       23       1,336             -            -          -      1,359
Common stock issued in connection with
    acquisition of additional interest
    in majority-owned subsidiary                  10,696        1         154             -            -          -        155
Translation adjustment                                 -        -           -            78            -          -         78
Net income, nine months ended
    September 30, 1995                                 -        -           -             -            -     11,872     11,872
                                              ----------   ------     -------   -----------   ----------    -------   --------

BALANCE AT SEPTEMBER 30, 1995                 21,222,356   $2,122     $74,790         $ (40)       $ 931    $38,190   $115,993
                                              ==========   ======     =======   ===========   ==========    =======   ========
</TABLE>
   The accompanying notes are an integral part of these financial statements.

                                 Page 5 of 18
<PAGE>
 
                   COMVERSE TECHNOLOGY, INC. AND SUBSIDIARIES

                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (UNAUDITED)
                                 (IN THOUSANDS)
 
 
                                                          NINE MONTHS ENDED
                                                            SEPTEMBER 30,
                                                            1994      1995
 
Cash flows from operating activities:
  Net cash from operations after adjustments
   for non-cash items                                    $ 11,230   $ 16,013
  Changes in assets and liabilities:
   Accounts receivable                                  (   5,474)   (12,275)
   Inventories                                          (   2,471)    (3,588)
   Prepaid expenses and other receivables               (     105)    (2,485)
   Accounts payable and accrued expenses                    5,048      8,016
   Advance payments from customers                            615       (256)
   Due to related parties                                     122         60
   Liability for severance pay                                564        979
                                                         --------   --------
Net cash provided by operating activities                   9,529      6,464
 
Cash flows from investing activities:
  Maturities and sales (purchases) of
    bank time deposits and investments, net             (  55,067)    43,130
  Purchases of property and equipment                   (   3,256)    (4,298)
  Increase in software development costs                (   2,099)    (3,688)
                                                         --------   --------
Net cash (used in) provided by investing activities     (  60,422)    35,144
 
Cash flows from financing activities:
  Decrease in short- and long-term debt, net            (     101)    (1,856)
  Proceeds from issuance of common stock                      217      1,359
                                                         --------   --------
Net cash provided by (used in) financing activities           116       (497)
 
Net increase (decrease) in cash and cash equivalents    (  50,777)    41,111
Cash and cash equivalents, beginning of period            119,438     39,225
                                                                    --------
Cash and cash equivalents, end of period                 $ 68,661   $ 80,336
                                                         ========   ========
 


              The accompanying notes are an integral part of these
                             financial statements.



                                 Page 6 of 18
<PAGE>
 
                   COMVERSE TECHNOLOGY, INC. AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)


 
            BASIS OF PRESENTATION.  The foregoing financial statements have been
  prepared by Comverse Technology, Inc. (the "Company" or "Comverse") and are
  unaudited.  All adjustments (which, except as hereinafter described, consist
  solely of normal recurring adjustments) have been made that, in the opinion of
  the Company's management, are necessary to present fairly the financial
  position, results of operations and cash flows for the interim periods
  presented.  The consolidated financial statements presented herein should be
  read in conjunction with the consolidated financial statements, and the notes
  thereto, for the year ended December 31, 1994.  The financial statements
  appearing herein have been restated to reflect the acquisition of Dale, Gesek,
  McWilliams & Sheridan, Inc. ("DGM&S") described below.  The results of
  operations for the nine and three month periods ended September 30, 1995 are
  not necessarily indicative of the results to be expected for any other interim
  period or the entire fiscal year.


            ACQUISITION OF DGM&S.  On August 30, 1995, the Company acquired
  DGM&S, a New Jersey corporation that develops and markets telecommunications
  software products.  To effect the acquisition, the Company issued 1,078,944
  shares of common stock for all the outstanding common stock of DGM&S.  The
  acquisition has been accounted for as a pooling of interests; therefore, prior
  financial statements and information have been restated to include DGM&S, as
  if the companies had been combined for all periods presented.

            Prior to the acquisition, DGM&S prepared its financial statements on
  the basis of a fiscal year ending September 30.  In 1995, the combined
  companies will report on the basis of Comverse's fiscal year, which ends on
  December 31.  To conform the financial reporting periods of the combined
  companies, DGM&S's operating results for the three month period ended December
  31, 1994, comprising total revenues and a net loss of approximately $2,122,000
  and $2,445,000, respectively, are reflected as an adjustment to retained
  earnings on the December 31, 1994 consolidated balance sheet, and the 1994
  interim financial statements appearing above reflect the combination of
  Comverse's results for the three and nine month periods ended September 30,
  1994 with DGM&S's results for the three and nine month periods ended June 30,
  1994.

            The table below sets forth the unaudited separate and combined
  results of Comverse and DGM&S for the three-month periods ended March 31,
  1995, June 30, 1995 and September 30,1995.


                                 Page 7 of 18
<PAGE>
 
                                              Three Months Ended
                                      March 31,     June 30,      September 30,
                                       1995          1995             1995
                                      --------      -------       ------------
                                                 (In Thousands)
                                                  (Unaudited)
                  
    Total Revenues
    --------------
     Comverse                          $28,744      $31,918         $34,044
     DGM&S                               2,778        3,894           4,550
     Less:  Intercompany eliminations        -            -            (269)
                                       -------      -------         -------
                                       $31,522      $35,812         $38,325
                                       =======      =======         =======
 
    Net Income
    ----------
 
     Comverse                          $ 3,517      $ 4,071         $ 4,418
     DGM&S                                (628)         205             310
     Less:  Intercompany eliminations        -            -             (21)
                                       -------      -------         -------
                                       $ 2,889      $ 4,276         $ 4,707
                                       =======      =======         =======
 
            INVENTORIES.  The composition of inventories at December 31, 1994
  and September 30, 1995 is as follows:

                                      DECEMBER 31,    SEPTEMBER 30,
                                         1994            1995
                                             (In Thousands)
            Raw materials              $ 7,196          $ 9,796
            Work in process              2,342            4,001
            Finished goods               2,889            2,218
                                       -------          -------
                                       $12,427          $16,015
                                       =======          =======
 

            RESEARCH AND DEVELOPMENT EXPENSES.  The Company has historically
  supported a substantial portion of its research and development activities
  through participation in government sponsored funding programs, which in
  general provide reimbursement for a portion of research and development
  expenditures incurred under project budgets approved on an annual basis by the
  applicable funding agencies.  During the nine month and three month periods
  ended September 30, 1995, gross research and development expenses amounted to
  approximately $19,806,000 and $7,078,000,  respectively, of which
  approximately $5,148,000 and $1,846,000, respectively, was reimbursed.

            EARNINGS PER SHARE. For the nine month and three month periods ended
  September 30, 1994 and 1995, the computation of earnings per share is based on
  the weighted average number of outstanding common shares and additional shares
  assuming the exercise of stock options. For the nine month and three month
  periods ended

                                 Page 8 of 18
<PAGE>
 
  September 30, 1994, the computation of fully diluted earnings per share was
  antidilutive. The shares used in the computations are as follows (also see
  Exhibit 11):
 
                           NINE MONTHS ENDED           THREE MONTHS ENDED
                             SEPTEMBER 30,                SEPTEMBER 30,
                             1994     1995              1994      1995
                                          (In Thousands)
 
          Primary           21,806   22,468            21,773    22,827
          Fully diluted     21,806   22,612            21,773    22,929
 


                                 Page 9 of 18
<PAGE>
 
  ITEM 2.  Management's Discussion and Analysis of
           Financial Condition and Results of Operations.
           --------------------------------------------- 

           RESULTS OF OPERATIONS.

           Total Revenues.  Total revenues for the nine month and three month
           --------------                                                    
  periods ended September 30, 1995 increased by approximately $22,924,000 (28%)
  and approximately $7,980,000 (26%), respectively, from the corresponding
  periods in 1994.  The increase is attributable primarily to a higher volume of
  sales of systems and parts.  Sales for the nine month and three month periods
  ended September 30, 1995 increased by approximately $20,308,000 (26%) and
  approximately $7,223,000 (25%), respectively, from the 1994 periods.  The
  growth in sales for the nine month period ended September 30, 1995 occurred in
  both the TRILOGUE and AUDIODISK product lines and for the three month period
  ended September 30, 1995 occurred in the TRILOGUE product line.  Interest and
  other income for the nine month and three month periods ended September 30,
  1995 increased by approximately $2,616,000 (67%) and approximately $757,000
  (52%), respectively, over the corresponding periods in 1994, resulting from
  increased interest rates and realized gains on sales of short-term
  investments.

            Cost of Sales.  Cost of sales for the nine month and three month
            -------------                                                   
  periods ended September 30, 1995 increased by approximately $7,970,000 (23%)
  and approximately $3,096,000 (25%), respectively, from the corresponding
  periods in 1994.  The increase is attributable primarily to the increase in
  sales.  Gross margin (expressed as a percentage of sales) for the nine month
  and three month periods ended September 30, 1995 increased to approximately
  57% from  approximately 56% during the corresponding 1994 periods.

            Research and Development Expenses.  Gross research and development
            ---------------------------------                                 
  expenses for the nine month and three month periods ended September 30, 1995
  increased by approximately $7,570,000 (62%) and approximately $2,630,000
  (59%), respectively, from the corresponding periods in 1994.  Net research and
  development expenses, after reimbursement under government funding programs,
  for the nine month and three month periods ended September 30, 1995 increased
  by approximately $5,565,000 (61%) and approximately $1,833,000 (54%),
  respectively, from the corresponding periods in 1994.  Such increases are due
  to the overall growth of research and development operations, the initiation
  of significant new research and development projects for both product lines,
  and increases in salaries and other costs associated with research and
  development operations in Israel.

            Selling, General and Administrative Expenses.  Selling, general and
            --------------------------------------------                       
  administrative expenses for the nine month and three month periods ended
  September 30, 1995 increased by approximately $5,553,000 (23%) and
  approximately $1,795,000 (20%), respectively, from the corresponding periods
  in 1994.  Such increases were the result of increased sales, marketing, and
  administrative activities associated with the overall growth of the Company's
  operations, and particularly with the expansion of direct sales and marketing
  activities internationally and in the United States.

                                 Page 10 of 18
<PAGE>
 
            Royalties and License Fees.  Royalties and license fees for the nine
            --------------------------                                          
  month and three month periods ended September 30, 1995 decreased by
  approximately $52,000 (3%) and approximately $33,000 (6%), respectively, from
  the corresponding periods in 1994.  Royalties and license fees for the nine
  and three month periods ended September 30, 1995, as a percentage of total
  sales, decreased from approximately 2.4% and approximately 2.0%, respectively,
  in the 1994 periods, to approximately 1.8% and approximately 1.5%,
  respectively, in the 1995 periods reflecting an increase in the proportion of
  total sales comprised of products bearing lower rates of royalty or for which
  no royalties are due.

            Income Tax Provision.  Provision for income taxes for the nine month
            --------------------                                                
  and three month periods ended September 30, 1995 increased by approximately
  $185,000 (14%) and approximately $227,000 (66%), respectively, from the
  corresponding periods in 1994.  The Company's overall effective tax rate
  decreased from approximately 13% during the nine month period ended September
  30, 1994 to approximately 11% in the corresponding period of 1995, and
  increased from approximately 9% during the three month period ended September
  30, 1994 to approximately 11% in the corresponding period in 1995.  The
  Company's overall rate of tax is reduced significantly by the tax benefits
  associated with qualified activities of one of its subsidiaries in Israel.

            Net Income.  Net income after taxes for the nine month and three
            ----------                                                      
  month periods ended September 30, 1995 increased by approximately $3,512,000
  (42%) and approximately $1,235,000 (36%), respectively, from the corresponding
  periods in 1994, primarily as a result of the factors described above.  Net
  income after taxes as a percentage of total revenues  increased to
  approximately 11.2% and approximately 12.3%, respectively, in the nine month
  and three month periods ended September 30, 1995 from approximately 10.1% and
  approximately 11.4%, respectively, in the corresponding periods in 1994.

            LIQUIDITY AND CAPITAL RESOURCES.  At September 30, 1995, the Company
  had cash and cash equivalents of approximately $80,336,000, bank time deposits
  and short-term investments of approximately $44,560,000 and working capital of
  approximately $149,085,000.  The Company believes that its existing working
  capital, together with funds generated from operations, will be sufficient to
  provide for its planned operations for the foreseeable future.

            The Company regularly examines opportunities for strategic
  acquisitions of other companies or lines of business.  Such acquisitions may
  require significant investment of capital, both in payment of the acquisition
  cost and in providing working capital for any acquired businesses.  There can
  be no assurance as to whether or when any acquired business would contribute
  positive operating results commensurate with the associated investment.  The
  Company anticipates that it may from time to time issue additional debt and/or
  equity securities either as direct consideration for such acquisitions or to
  raise additional funds to be used (in whole or in part) in payment for
  acquired securities or assets.  The issuance of such securities could be
  expected to have a dilutive impact on the Company's shareholders.

                                 Page 11 of 18
<PAGE>
 
            The Company's liquidity and capital resources have not been, and are
  not anticipated to be, materially affected by restrictions pertaining to the
  ability of its foreign subsidiaries to pay dividends or by withholding taxes
  associated with any such dividend payments.

            CERTAIN TRENDS AND UNCERTAINTIES. The industries in which the
  Company is principally involved are characterized by frequent technological
  and market changes and are highly competitive.  The Company faces competition
  from a variety of sources, including competitors that are larger than the
  Company and have more established positions in certain market segments.

            The voice processing and message management industry has experienced
  a continuing evolution of product offerings and alternatives for delivery of
  services.  These trends have affected and may be expected to have a
  significant continuing influence on conditions in the industry, although the
  impact on the industry generally and on the Company's position in the industry
  cannot be predicted with assurance.  Significant changes in the industry make
  planning decisions more difficult and increase the risk inherent in the
  planning process.

            The market for telecommunications monitoring systems is also in a
  period of significant transition.  Budgetary constraints, uncertainties
  resulting from the introduction of new technologies in the telecommunications
  environment and shifts in the pattern of government expenditures resulting
  from geopolitical events have increased uncertainties in the market, resulting
  in certain instances in the attenuation of government procurement programs
  beyond their originally expected performance periods and an increased
  incidence of delay, cancellation or reduction of planned projects.  Sales to
  government customers may also be affected by decisions of certain government
  agencies to increase their internal product development capabilities, with a
  concomitant reduction in their procurements from third party vendors.
  Competitive conditions in this sector have also been affected by the efforts
  of government contractors, particularly developers and integrators of
  technology products, to redirect their marketing strategies and product plans
  in reaction to cut-backs in their traditional areas of focus, resulting in an
  increase in the number of competitors and the range of products offered in
  response to particular requests for proposals.  The lack of predictability in
  the timing and scope of government procurements have similarly made planning
  decisions more difficult and have increased the associated risks.

            The Company has historically derived a significant portion of its
  revenue and operating profit from a relatively small number of contracts for
  large system installations with customers in both the commercial and
  government sectors.  While the growth of the Company's business has reduced
  its dependence on any specific customers, it continues to emphasize large
  capacity systems in its product development and marketing strategies.
  Contracts for large system installations typically involve a lengthy and
  complex bidding and selection process, and the ability of the Company to
  obtain particular contracts is inherently difficult to predict. The Company
  believes that opportunities for these installations will continue to grow in
  both its commercial and government markets, and intends to continue to expand
  its research and development,

                                 Page 12 of 18
<PAGE>
 
  manufacturing, sales and marketing and product support capabilities in
  anticipation of such growth. However, the timing and scope of these
  opportunities and the pricing and margins associated with any eventual
  contract award are difficult to forecast, and may vary substantially from
  transaction to transaction. The Company's future operating results may
  accordingly exhibit a higher degree of volatility than the operating results
  of other companies in its industries that have adopted different strategies,
  and than the Company has experienced in prior periods. Although the Company is
  actively pursuing a number of significant procurement opportunities in the
  United States and internationally, both the timing of any eventual
  procurements and the probability of the Company's receipt of significant
  contract awards are uncertain. The degree of dependence by the Company on
  large orders, and the investment required to enable the Company to perform
  such orders, without assurance of continuing order flow from the same
  customers and predictability of gross margins on any future orders, increase
  the risk associated with its business.

            The Company has significantly increased its expenditures in all
  areas of its operations during recent periods, including the areas of research
  and development and marketing and sales, and the Company plans to further
  increase these for the foreseeable future.  The increase in research and
  development expenditures reflects the Company's concentration on enhancing the
  range of features and capabilities of its existing product lines and
  developing new generations of its products.  The Company believes that these
  efforts are essential for the long- and short-term competitiveness of its
  product offerings and for positioning itself to participate in future growth
  opportunities in both the commercial and government sectors.  The increase in
  sales and marketing expenditures primarily results from the Company's decision
  to expand its activities and direct presence in a number of world markets.
  The Company's costs of operations have also been affected by increases in the
  cost of its operations in Israel, resulting both from general inflation and
  increases in the cost of attracting and retaining qualified scientific,
  engineering and technical personnel in Israel, where the demand for such
  personnel is growing rapidly with the expansion of technology-based industries
  in that country.  The increase in these costs in recent periods has not been
  offset by proportional devaluation of the Israeli shekel against the U.S.
  dollar, and accordingly has had a negative impact on the Company's overall
  results of operations.

            The Company currently derives a majority of its total revenues from
  sales to customers outside of the United States.  International transactions
  involve particular risks, including political decisions affecting tariffs and
  trade conditions, rapid and unforeseen changes in economic conditions in
  individual countries, turbulence in foreign currency and credit markets, and
  increased costs resulting from lack of proximity to the customer.  Volatility
  in international currency exchange rates may have a significant impact on the
  Company's operating results to the extent that it is unable to completely
  hedge the exchange rate risk of long term contracts denominated in foreign
  currencies, or by the cost of such hedging.

           The trading price of the Company's shares may be affected by the
  factors noted above as well as prevailing economic and financial trends and
  conditions in the public securities markets.  During recent periods, share
  prices of companies in technology and government contracting businesses, and
  particularly smaller and medium-sized

                                 Page 13 of 18
<PAGE>
 
  publicly traded companies such as the Company, have exhibited a high degree of
  volatility. Shortfalls in revenues or earnings from the levels anticipated by
  the public markets could have an immediate and significant effect on the
  trading price of the Company's shares in any given period. Such shortfalls may
  result from events that are beyond the Company's immediate control, can be
  unpredictable and, since a significant proportion of the Company's sales
  during each fiscal quarter tend to occur in the latter stages of the quarter,
  may not be discernible until the end of a financial reporting period, which
  may contribute to the volatility of the trading value of its shares regardless
  of the Company's long-term prospects. The trading price of the Company's
  shares may also be affected by developments, including reported financial
  results and fluctuations in trading prices of the shares of other publicly-
  held companies in the voice processing industry, which may not have any direct
  relationship with the Company's business or prospects.

                                 Page 14 of 18
<PAGE>
 
                                    PART II

                               Other Information
                               -----------------

  ITEM 6.  Exhibits and Reports on Form 8-K.
           -------------------------------- 
 
 
  (a)      Exhibit Index.
           --------------
 
           Item
           Number    Exhibit                                Page
           ------    -------                                ----
 
             11.     Statement re: computation of
                     per share earnings                   17 - 18
 
             27.     Financial data schedule        Filed electronically
 
  (b)      Reports on Form 8-K.
           ------------------- 

           None


                                 Page 15 of 18
<PAGE>
 
                                   SIGNATURES
                                   ----------


        Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused this report to be signed on its behalf by the
  undersigned thereunto duly authorized.


                                     COMVERSE TECHNOLOGY, INC.


  Dated:  November 7,  1995          S / Kobi Alexander
                                     ------------------
                                     Kobi Alexander
                                     President, Chairman of the Board
                                     and Chief Executive Officer


  Dated:  November 7, 1995           S / Igal Nissim
                                     ---------------
                                     Igal Nissim
                                     Vice President, Finance
                                     and Chief Financial Officer




                                 Page 16 of 18

<PAGE>
 
                                                                      EXHIBIT 11

                           COMVERSE TECHNOLOGY, INC.

                 STATEMENT OF COMPUTATION OF EARNINGS PER SHARE
                                  (UNAUDITED)
                     (IN THOUSANDS, EXCEPT PER SHARE DATA)
 
 
                                                        THREE  MONTHS ENDED
                                                           SEPTEMBER 30,
                                                         1994 (1)     1995
 
Primary earnings per share:
 
    Net income                                           $  3,472    $ 4,707
                                                         ========    =======
 
Weighted average number of outstanding common shares       20,942     21,146
Additional shares assuming exercise of stock options          831      1,681
                                                         --------    -------
Weighted average number of outstanding common
 and common equivalent shares                              21,773     22,827
                                                         ========    =======
 
Primary earnings per share                               $   0.16    $  0.21
                                                         ========    =======

 
Fully diluted earnings per share:

    Net income                                                        $4,707
                                                                      ======
 
 
Weighted average number of outstanding common shares                  21,146
Additional shares assuming exercise of stock options                   1,783
                                                                     -------
Weighted average number of outstanding common shares
  assuming full dilution                                              22,929
                                                                     =======
 
Fully diluted earnings per share                                     $  0.21
                                                                     =======
 

(1) Fully diluted earnings per share for the three month period ended September
    30, 1994 were antidilutive and are omitted.



                                 Page 17 of 18
<PAGE>
 
                                                                      EXHIBIT 11
                                                                     (continued)
                           COMVERSE TECHNOLOGY, INC.

                 STATEMENT OF COMPUTATION OF EARNINGS PER SHARE
                                  (UNAUDITED)
                     (IN THOUSANDS, EXCEPT PER SHARE DATA)
 
 
                                                        NINE  MONTHS ENDED
                                                           SEPTEMBER 30,
                                                        1994 (1)     1995
[S]                                                     [C]        [C]
 
Primary earnings per share:
 
    Net income                                           $ 8,360    $11,872
                                                         =======    =======
                                                         
Weighted average number of outstanding common shares      20,921     21,061
Additional shares assuming exercise of stock options         885      1,407
                                                         -------    -------
Weighted average number of outstanding common            
   and common equivalent shares                           21,806     22,468
                                                         =======    =======
                                                         
Primary earnings per share                               $  0.38    $  0.53
                                                         =======    =======
 

Fully diluted earnings per share:

    Net income                                                      $11,872
                                                                    =======


Weighted average number of outstanding common shares                 21,061
Additional shares assuming exercise of stock options                  1,551
                                                                    -------
Weighted average number of outstanding common shares
  assuming full dilution                                             22,612
                                                                    =======
 
Fully diluted earnings per share                                    $  0.53
                                                                    =======
 

(1) Fully diluted earnings per share for the nine month period ended September
    30, 1994 were antidilutive and are omitted.



                                 Page 18 of 18

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 10-Q
FOR 9/30/95 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<RESTATED><F1>
<MULTIPLIER> 1,000
       
<S>                             <C>                     <C>                     <C>                     <C>
<PERIOD-TYPE>                   12-MOS                   3-MOS                   6-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1994             DEC-31-1995             DEC-31-1995             DEC-31-1995
<PERIOD-START>                             JAN-01-1994             JAN-01-1995             JAN-01-1995             JAN-01-1995
<PERIOD-END>                               DEC-31-1994             MAR-31-1995             JUN-30-1995             SEP-30-1995
<CASH>                                          39,225                  48,104                  67,412                  80,336
<SECURITIES>                                    89,368                  76,456                  63,913                  44,560
<RECEIVABLES>                                   24,181                  25,417                  28,891                  35,187
<ALLOWANCES>                                         0                       0                       0                       0
<INVENTORY>                                     12,427                  15,539                  15,208                  16,015
<CURRENT-ASSETS>                               169,792                 171,180                 180,353                 182,636
<PP&E>                                          17,162                  18,250                  19,618                  21,460
<DEPRECIATION>                                 (8,119)                 (8,710)                 (9,433)                (10,202)
<TOTAL-ASSETS>                                 192,502                 198,980                 209,233                 213,268
<CURRENT-LIABILITIES>                           28,448                  30,113                  34,684                  33,551
<BONDS>                                         60,000                  60,000                  60,000                  60,000
<COMMON>                                         2,098                   2,101                   2,110                   2,122
                                0                       0                       0                       0
                                          0                       0                       0                       0
<OTHER-SE>                                      99,515                 102,818                 108,549                 113,871
<TOTAL-LIABILITY-AND-EQUITY>                   192,502                 198,980                 209,233                 213,268
<SALES>                                        108,150<F2>              29,383                  63,010                  99,126
<TOTAL-REVENUES>                               114,312<F2>              31,522                  67,334                 105,659
<CGS>                                           47,715<F2>              12,921                  27,214                  42,879
<TOTAL-COSTS>                                  100,431<F2>              28,229                  59,265                  92,313
<OTHER-EXPENSES>                                     0                       0                       0                       0
<LOSS-PROVISION>                                     0                       0                       0                       0
<INTEREST-EXPENSE>                               3,947<F2>               1,210                   2,442                   3,459
<INCOME-PRETAX>                                 13,881<F2>               3,293                   8,069                  13,346
<INCOME-TAX>                                     1,783<F2>                 404                     904                   1,474
<INCOME-CONTINUING>                             12,098<F2>               2,889                   7,165                  11,872
<DISCONTINUED>                                       0                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0                       0
<CHANGES>                                            0                       0                       0                       0
<NET-INCOME>                                    12,098<F2>               2,889                   7,165                  11,872
<EPS-PRIMARY>                                     0.55<F2>                0.13                    0.32                    0.53
<EPS-DILUTED>                                     0.55<F2>                0.13                    0.32                    0.53
<FN>
<F1>December 1994, March 1995 and June 1995 amounts are restated to reflect pooling of interests with Dale, Gesek, McWilliams & 
Sheridan, Inc. ("DGM&S").
<F2>DGM&S' fiscal year-end was September 30.  Accordingly, reflects combination
of Comverse results for year-end December 1994 with DGM&S results for
year-end September 1994. DGM&S results for the three month period ended
December 1994 are reflected as an adjustment to retained earnings.
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission